Table of Contents
Fetching ...

DTI-GP: Bayesian operations for drug-target interactions using deep kernel Gaussian processes

Bence Bolgár, András Millinghoffer, Péter Antal

TL;DR

The paper tackles uncertainty-aware DTI prediction by introducing DTI-GP, a deep kernel Gaussian process that fuses chemical fingerprints and protein embeddings to deliver probabilistic predictions. By sampling from the predictive distribution, it constructs a Bayesian precedence matrix to enable top-$K$ selection, ranking, and rejection-based enrichment, with two practical heuristics (Score and Eigen). Compared to DeepDTA and SparseChem on the KIBA benchmark with scaffold-based splits, DTI-GP achieves superior performance in early-discovery regimes and provides calibrated posterior distributions. The work demonstrates the practical value of Bayesian operations for decision-making in drug discovery and outlines avenues for active learning and ranking-focused extensions.

Abstract

Precise probabilistic information about drug-target interaction (DTI) predictions is vital for understanding limitations and boosting predictive performance. Gaussian processes (GP) offer a scalable framework to integrate state-of-the-art DTI representations and Bayesian inference, enabling novel operations, such as Bayesian classification with rejection, top-$K$ selection, and ranking. We propose a deep kernel learning-based GP architecture (DTI-GP), which incorporates a combined neural embedding module for chemical compounds and protein targets, and a GP module. The workflow continues with sampling from the predictive distribution to estimate a Bayesian precedence matrix, which is used in fast and accurate selection and ranking operations. DTI-GP outperforms state-of-the-art solutions, and it allows (1) the construction of a Bayesian accuracy-confidence enrichment score, (2) rejection schemes for improved enrichment, and (3) estimation and search for top-$K$ selections and ranking with high expected utility.

DTI-GP: Bayesian operations for drug-target interactions using deep kernel Gaussian processes

TL;DR

The paper tackles uncertainty-aware DTI prediction by introducing DTI-GP, a deep kernel Gaussian process that fuses chemical fingerprints and protein embeddings to deliver probabilistic predictions. By sampling from the predictive distribution, it constructs a Bayesian precedence matrix to enable top- selection, ranking, and rejection-based enrichment, with two practical heuristics (Score and Eigen). Compared to DeepDTA and SparseChem on the KIBA benchmark with scaffold-based splits, DTI-GP achieves superior performance in early-discovery regimes and provides calibrated posterior distributions. The work demonstrates the practical value of Bayesian operations for decision-making in drug discovery and outlines avenues for active learning and ranking-focused extensions.

Abstract

Precise probabilistic information about drug-target interaction (DTI) predictions is vital for understanding limitations and boosting predictive performance. Gaussian processes (GP) offer a scalable framework to integrate state-of-the-art DTI representations and Bayesian inference, enabling novel operations, such as Bayesian classification with rejection, top- selection, and ranking. We propose a deep kernel learning-based GP architecture (DTI-GP), which incorporates a combined neural embedding module for chemical compounds and protein targets, and a GP module. The workflow continues with sampling from the predictive distribution to estimate a Bayesian precedence matrix, which is used in fast and accurate selection and ranking operations. DTI-GP outperforms state-of-the-art solutions, and it allows (1) the construction of a Bayesian accuracy-confidence enrichment score, (2) rejection schemes for improved enrichment, and (3) estimation and search for top- selections and ranking with high expected utility.
Paper Structure (13 sections, 8 equations, 8 figures, 2 tables)

This paper contains 13 sections, 8 equations, 8 figures, 2 tables.

Figures (8)

  • Figure 1: DTI-GP model with two neural networks learning molecule and sequence representations and a Gaussian process classification model computing probabilistic outputs.
  • Figure 2: ROC and PR curves in the global evaluation setting. The GP-based model outperforms DeepDTA, especially in the region relevant for early discovery and top-$K$ selection.
  • Figure 3: Reliability plot of the proposed model. Note that both the Bayesian and MAP estimations suffer from overconfidence in the relevant high-probability region.
  • Figure 4: Difference between the score and eigenvector-based heuristics. The eigenvector-based method assigns values close to $0$ to most interactions; the score-based method distributes values more evenly.
  • Figure 5: Relationship between the set size $K$ and false discovery rates. The score and eigenvector-based heuristics outperform DeepDTA, SparseChem and DTI-GP-MAP in the small set size region. The right side of the figure is somewhat noisy, as expected with such small set sizes.
  • ...and 3 more figures